Search - tctmd.com

Displaying 41 - 60 of 118

Sort: Relevancy | Date

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

Todd Neale

December 28, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

Presentation Interventional Complications 2022

Transcatheter Mitral Valve Edge to Edge Repair: Argh, my gradient is 8 mmHg!

Presenter: Chad Rammohan

July 15, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Todd Neale

February 02, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

Presentation Controversies and Advances 2021

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Presenter: Raj R. Makkar

December 03, 2021

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

L.A. McKeown

November 23, 2021

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News EACTS 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Michael O'Riordan

October 18, 2021

Advertisement

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 2022 News Roundup

September 2022 News Roundup

Transcatheter Mitral Valve Edge to Edge Repair: Argh, my gradient is 8 mmHg!

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content